aluminum sulfate has been researched along with Infections, Staphylococcal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Biswas, L; Biswas, R; Suresh, MK; Vasudevan, AK | 1 |
| Haghighat, S; Mahdavi, M; Mortazavi, SS | 1 |
| Abparvar, AA; Ahmadi, K; Davoodian, P; Eftekhar, E; Einakian, MA; Faezi, S; Ghaedi, T; Hassaniazad, M | 1 |
| Ahmed, R; Anjum, AA; Aqib, AI; Aslam, HB; Farooqi, SH; Hussain, K; Hussain, R; Ijaz, M; Mehmood, K; Zhang, H | 1 |
| Arsalan, M; Azmi, MLM; Bhutto, KR; Hambali, IU; Jefri, MN; Jesse, FFA; Lawan, A; Muhammad, NA; Odhah, MN; Wahid, AH; Zakaria, Z | 1 |
| Ellis, MW; Fahim, RE; Fattom, A; Fraser, J; Hospenthal, DR; Kessler, PD; Lalani, T; Landrum, ML; Maguire, JD; Niknian, M; Taylor, K; Tribble, DR; Wilkins, K | 1 |
| Hayakawa, Y; Hu, DL; Hyodo, M; Karaolis, DK; Nakane, A; Narita, K | 1 |
| Hu, DL; Iwakura, Y; Mori, F; Nakane, A; Narita, K; Wakabayashi, K | 1 |
| Fitch, RW; Ghosh, SK; Roy Chowdhury, R | 1 |
1 trial(s) available for aluminum sulfate and Infections, Staphylococcal
| Article | Year |
|---|---|
Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alum Compounds; Antibodies, Bacterial; Antibodies, Neutralizing; Bacterial Toxins; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Exotoxins; Female; Healthy Volunteers; Hemolysin Proteins; Humans; Immunoglobulin G; Leukocidins; Male; Middle Aged; Placebos; Staphylococcal Infections; Staphylococcal Vaccines; Toxoids; Vaccines, Synthetic; Young Adult | 2017 |
8 other study(ies) available for aluminum sulfate and Infections, Staphylococcal
| Article | Year |
|---|---|
Protective efficacy of Alum adjuvanted Amidase protein vaccine against Staphylococcus aureus infection in multiple mouse models.
Topics: Alum Compounds; Amidohydrolases; Animals; Antibodies, Bacterial; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Staphylococcal Infections; Staphylococcal Vaccines; Staphylococcus aureus; Vaccine Efficacy; Vaccines | 2022 |
Recombinant PBP2a of methicillin-resistant S. aureus formulation in Alum and Montanide ISA266 adjuvants induced cellular and humoral immune responses with protection in Balb/C mice.
Topics: Adjuvants, Pharmaceutic; Alum Compounds; Animals; Antibodies, Bacterial; Bacterial Proteins; Drug Compounding; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G; Interleukin-17; Interleukin-4; Mannitol; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Penicillin-Binding Proteins; Staphylococcal Infections | 2020 |
Protective efficacy of Hla-MntC-SACOL0723 fusion protein adjuvanted in alum and MPL against Staphylococcus aureus sepsis infection in mice.
Topics: Alum Compounds; Animals; Female; HLA Antigens; Immunoglobulin G; Interleukin-17; Interleukin-4; Kidney; Lipid A; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Periplasmic Binding Proteins; Recombinant Fusion Proteins; Sepsis; Staphylococcal Infections; Staphylococcal Vaccines; Staphylococcus aureus; Up-Regulation | 2021 |
Development and evaluation of vaccine against Staphylococcus aureus recovered from naturally occurring mastitis in she-camels.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Load; Bacterial Proteins; Camelus; Coagulase; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Female; Hemolysin Proteins; Immunization, Secondary; Immunogenicity, Vaccine; Mastitis; Mineral Oil; Rabbits; Staphylococcal Infections; Staphylococcal Vaccines; Staphylococcus aureus; Time Factors; Vaccination; Vaccines, Inactivated | 2018 |
Clinical responses in cows vaccinated with a developed prototype killed Staphylococcus aureus mastitis vaccine.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Bacterial Vaccines; Cattle; Injections, Intramuscular; Mastitis, Bovine; Staphylococcal Infections; Staphylococcal Vaccines; Staphylococcus aureus; Treatment Outcome | 2018 |
c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Bacterial; Antigens, Bacterial; Coagulase; Colony Count, Microbial; Cyclic GMP; Enterotoxins; Female; Immunoglobulin G; Injections, Subcutaneous; Liver; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Spleen; Staphylococcal Infections; Staphylococcal Vaccines | 2009 |
Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Cells, Cultured; Coagulase; Immunity, Cellular; Interleukin-17; Kidney; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Protein Structure, Tertiary; Spleen; Staphylococcal Infections; Staphylococcal Vaccines; Staphylococcus aureus | 2010 |
Efficacy of phytol-derived diterpenoid immunoadjuvants over alum in shaping the murine host's immune response to Staphylococcus aureus.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Bacterial; Cytokines; Diterpenes; Female; Mice; Mice, Inbred BALB C; Phytol; Staphylococcal Infections; Staphylococcal Vaccines; Staphylococcus aureus; T-Lymphocytes; Vaccines, Inactivated | 2013 |